T he emergence of the influenza A(H1N1)pdm09 virus (hereafter referred to as pH1N1) in the spring of 2009 led the World Health Organization to declare a pandemic. 1 An estimated 60 million Americans (20% of the US population) were infected with pH1N1 from April 2009 through February 2010; roughly 270,000 pH1N1-related hospitalizations and 12,000 pH1N1-related deaths occurred during this same time period. 2 In the fall and winter of 2009-2010, few Americans knew the course that the pandemic would take. The crisis was widely covered by US media and included numerous calls by federal and state public health officials to obtain pH1N1 vaccinations promptly. To what extent did Americans respond to these messages from public health officials to obtain pH1N1 vaccinations? In particular, how quickly did American parents obtain pH1N1 vaccinations for their children? The latter is a compelling question because early findings by public health agencies suggested that younger persons were at higher risk of contracting the pH1N1 virus than older persons. Moreover, children and adolescents play an important role in the transmission of influenza to healthy individuals, such that vaccinating healthy children can reduce the spread and costs of possible pandemics. [3] [4] [5] [6] [7] [8] [9] Previous papers have addressed these questions, but many were based on regional data obtained from hospitals or immunization registries. [10] [11] [12] Although some of these datasets contained sizable numbers of observations, the number of explanatory variables available for analysis was often limited, plus results could not be generalized to the US child population. This paper extends earlier research by using the 2010 National Health Interview Survey (NHIS), which contains a nationally representative sample of children, to estimate receipt of pH1N1 vaccinations by January 1, 2010 among noninstitutionalized children in the United States.
BACKGROUND
Although seasonal influenza typically strikes elderly persons the hardest, early analyses by the Centers for Disease Control and Prevention (CDC) indicated that the median age of persons with laboratory-confirmed pH1N1 infections in the United States as of July 31, 2009 , was 12 years, the highest infection incidence was among persons aged 5-24 years, and the incidence of hospitalization was highest among children aged 4 years or younger. 1 Consequently, CDC's Advisory Committee on Immunization Practices (ACIP) recommended in late July 2009 that initial vaccination efforts target several subpopulations, including persons aged 6 months-24 years, and that children under 10 years of age needed 2 doses at least 21 days apart to induce immunity to the virus, whereas older children required 1 dose. 1 Distribution of pH1N1 vaccine in the United States began on October 5, 2009, with state public health departments receiving initial vaccine supplies in amounts proportional to their populations. 13 
METHODS

Data, Analytic Sample, and Key Measures
Data from the 2010 NHIS were used for this analysis. Conducted by the CDC's National Center for Health Statistics (NCHS), NHIS collects information about the health and health care of the civilian noninstitutionalized population of the United States from a representative sample of households across the country. Information on all family members was typically collected during face-to-face interviews with Z1 members present at the time of interview. One child (0-17 y of age) per family was randomly selected as the sample child, and more in-depth information regarding this child was collected from a knowledgeable adult proxy respondent, typically a parent, residing in the household. Previous reports of influenza vaccination coverage have yielded comparable estimates regardless of whether data were based on 1 randomly selected child or all children in the family. 14 The final response rate for the 2010 NHIS Sample Child file was 70.7%. 15 Several questions about receipt of pH1N1 vaccinations were added to the NHIS Sample Child questionnaire fielded in January 2010. Interviewers asked whether the sample child had received a pH1N1 flu vaccination (either by shot or nasal spray) since October 2009. If so, the interviewer asked how many vaccinations the sample child had received, and then asked the month and year of the first dose. If a second dose was received, the interviewer asked the month and year of that dose. Sample children without a valid year regarding the first and/or second pH1N1 vaccination were excluded from the analyses (n = 22).
Age eligibility for this analysis was determined by the sample child's age on October 5, 2009, rather than his or her age at interview to insure that all cases in the analysis were at least 6 months old sometime during the first 3 months that the vaccine was available (348 cases were excluded because they were too young to receive the vaccine). For those sample children with complete birthdate information (ie, month, day, and year), all children who were 4.5 months or older on October 5, 2009 were included in the analysis; for sample children without complete birthdate information, age at interview was used but sample children under 1 year of age were excluded (n = 19).
The pH1N1 questions were dropped from the NHIS instrument in late July 2010, when a single vaccine containing immunizations against both seasonal and pH1N1 influenzas was widely available. The analysis was thus restricted to the first 32 weeks of 2010 when the survey specifically asked about receipt of pH1N1 vaccinations. Consequently, the sample child case weight was adjusted by a factor of 1.625 (52 divided by 32) to obtain results that are generalizable to the US child population in 2010. Sufficient information regarding month and year of the first pH1N1 dose was obtained for 96% of sample children included in the NHIS during January-July, 2010.
Outcome Measures
Given that the vaccine first became available on October 5, 2009, a model was developed to estimate receipt of a first vaccination among age-eligible children by January 1, 2010 . This guarantees that all sample children would have had the same opportunity to obtain vaccinations in the final months of 2009, before their family was interviewed in 2010. For children under 10 years of age who received their first dose by January 1, a second model estimated which children received their second dose by February 1, 2010, assuming a 3-to 4-week interval between the first and second doses, 16 although previous research suggests that the second dose was likely delayed for most children. 17 Some interviews for the 2010 survey year may have been conducted before children could receive their second dose by February 1. However, interviewing for the 2010 NHIS did not begin until January 18, so the number of cases was likely small. January interview dates for all children under age 10 who received their first vaccinations in December were examined, and censoring was a possibility in only 5-6 cases.
Explanatory Measures
Demographic variables in the analysis included the child's age, sex, race/ethnicity, and family structure. Child's age on October 5, 2009 was collapsed into 1 of 2 age groups: 4.5 months through 9 years versus 10 years through 17 years to distinguish younger from older children, reflecting the ACIP recommendations. Regarding race/ethnicity, children were categorized as Hispanic, non-Hispanic black, nonHispanic other (eg, Asian, Native American or Alaska Native, or Native Hawaiian or Other Pacific Islander children), and non-Hispanic white to test for immunization disparities by race or ethnicity. 10, 11, 18 Family structure was measured by 7 mutually exclusive variables reflecting parental marital status as well as type of relationship (eg, biological, adoptive, step) between all children 0-17 years of age living in the family at the time of the interview and any parents present (Table 1) , in a manner consistent with previous studies that have used detailed family structure indicators to examine children's living arrangements and health outcomes. [19] [20] [21] Because the NHIS defines children as family members who are 0-17 years of age and adults as family members who are aged 18 or older, adult children aged 18 or older in the NHIS are considered related adults regardless of their relationship to their parents. 15 Several explanatory variables also measured characteristics and resources of the parents or family, including parental education [less than high school diploma, high school diploma or General Educational Development high school equivalency diploma (GED), some college, and college degree], region (Northeast, Midwest, South, and West), and place of residence. Regarding parental education, education of the parent with the higher level of education was utilized, regardless of that parent's age, to reflect the parent's ability to interact with and understand the health care system (per social capital theory). If the child's parents did not reside in the household or if education of resident parent(s) was missing, then parental education was unknown (n = 268). Place of residence identified families residing in a central city, a suburb, or in a nonmetro area at the time of interview. Region and place of residence have been utilized in previous research as proxy indicators of provider supplies. 22 Measures of family resources were also included in the models, such as income; health insurance coverage; receipt of a well-child checkup (ie, a general checkup received when the sample child was not sick or injured) in the past 12 months; receipt of special education; and receipt of supplemental nutrition benefits for Women, Infants, and Children, or WIC. Poverty ratios in the 2010 NHIS Imputed Income files were utilized to eliminate missing income information; these ratios were based on the family's income from all sources and before taxes in the previous calendar year relative to the appropriate 2009 poverty threshold defined by the US Census Bureau. 23 The imputed ratios were collapsed into 1 of 4 mutually exclusive variables: strictly below the federal poverty threshold (< 1.00); 1.00 to <2 times the federal poverty threshold; 2.00 to <4 times the federal poverty threshold; and 4.00 times the poverty threshold or more.
Health insurance coverage was measured at the time of interview and was indicated by 3 variables: children with private coverage, any public coverage (eg, Medicaid, State Children's Health Insurance Program, military health plans, etc.), and those without any health insurance coverage. Indicators of participation in special education and receipt of benefits from the special supplemental nutrition program for Women, Infants, and Children (WIC), at any time during the previous year were also included because there is evidence suggesting that some states took advantage of existing local assistance programs and school systems to increase vaccinations. 18, 24 Researchers at CDC 25 found that 58% of children hospitalized with the pH1N1 virus during April 2009-February 2010 had at least 1 underlying condition; 33% of these children had asthma, 11% had neurological/developmental disabilities, 8% had moderately severe developmental delay conditions, 6% had seizure disorders, 5% had chronic lung conditions, 5% had blood disorders (including sickle cell anemia), 3% had cerebral palsy, and 1% had diabetes. It is therefore likely that children with underlying chronic conditions might be more likely to receive pH1N1 vaccinations simply because they are sicker and need more medical attention. Chronic condition status was derived from a series of questions that asked whether a doctor or other health professional had ever said that the sample child had mental retardation, any other developmental delay, Down syndrome, cerebral palsy, muscular dystrophy, cystic fibrosis, sickle cell anemia, autism, diabetes, arthritis, congenital heart disease, another heart condition, and, in the past 12 months, anemia or seizures. Children with none of these conditions were distinguished from those with 1, or Z2 such conditions. Children who had ever been diagnosed with asthma and still had it when interviewed were included in a separate measure apart from chronic condition status due to the large percentage of children with asthma who were hospitalized for pH1N1. 25 Lastly, the NHIS does not ask questions that ascertain respondents' trust in health services, immunizations, or the public health system, so previous behavior-children's receipt of a seasonal flu vaccination sometime during the year before the H1N1 vaccination became available-served as a proxy for parental trust in the safety and benefits of flu immunizations, which may in turn have translated into a greater willingness to heed warnings of public health officials regarding the pH1N1 pandemic and the importance of timely vaccination(s) for their children. 26 Therefore, the models included a measure of receipt of a seasonal flu vaccination in the past year but before October 2009 when pH1N1 vaccinations became available.
Statistical Analyses
Two logistic regression models were fitted to estimate receipt of a first pH1N1 vaccination before January 1, 2010 (among all US children aged 4.5 mo through 17 y), and then receipt of a second vaccination before February 1, 2010 (among US children aged 4.5 mo through 9 y who had a first vaccination by January 1, 2010). Note that these models are based on 5601 and 972 observations, respectively, after cases with missing information were removed. Unweighted analyses using methodology described by Allison 27 tested for multicollinearity issues; none were detected. All analytic results in the tables were conducted using SUDAAN 11.0 to account for the complex sample design of the NHIS. 28 Because receipt of pH1N1 vaccinations was not a rare event-nearly 29% of US children had received a pH1N1 vaccination by January 1, 2010-relative risk ratios rather than odds ratios were estimated, 29, 30 using the procedures described by Bieler et al. 31 Table 2 shows unweighted frequencies, counts of cases with missing information, and weighted population percentages for all analytic variables.
Adjusted relative risk ratios (ARR) and 95% confidence intervals derived from the first model predicting receipt of a first pH1N1 vaccination by January 1, 2010, are shown in Table 3 .
Younger children (4.5 mo through 9 y on October 5, 2009) were 29% more likely than older children aged 10-17 years to have received a pH1N1 vaccination by January 1, 2010 (ARR = 1.29), whereas children in cohabiting and extended families were 33% and 18%, respectively, less likely than children in nuclear families to have received a pH1N1 vaccination by this date. Non-Hispanic black children were 25% less likely than non-Hispanic white children to have received a vaccination by January 1, 2010, whereas non-Hispanic other children were 22% more likely than non-Hispanic white children to have received a vaccination. Children in families where the more educated parent did not attend any college decreased the likelihood that a child received a first pH1N1 vaccination by 18%-28%. Children living in the West were 19% less likely than children in the Northeast to have received a vaccination by January 1, 2010; no other regional differences were detected. Children living in families that were <4 times the federal poverty threshold were 23%-31% less likely to receive the first pH1N1 vaccination by January 1, 2010. However, receipt of WIC benefits and public health insurance coverage offset these income effects, increasing the likelihood of a first pH1N1 vaccination by 19% and 23%, respectively. Receipt of a seasonal flu vaccination before October 2009 also increased the likelihood that a child received a first pH1N1 vaccination by 39%. Note that uninsured children and those with private health insurance were equally likely to have received a vaccination by January 1, 2010 (although note that the ARR for uninsured children was 0.79).
Children with asthma or Z1 chronic conditions were not any more likely to have received a pH1N1 vaccination by January 1, 2010 than children without these conditions. (Preliminary analyses that included asthma as a chronic condition yielded the same finding.) Other explanatory variables such as children's general health, disability status, having respiratory allergies and hay fever were also examined, but these were not retained in the analysis because they added no explanatory information to the model. Risk ratios obtained from the second logistic model are shown in Table 4 .
Four variables were significantly associated with receipt of a second pH1N1 vaccination among younger children by February 1, 2010. Children living in single parent, unmarried biological or adoptive, or blended families were less likely than children in nuclear families to have received a second vaccination (ARR = 0.60, 0.44, and 0.60, respectively). In addition, 
DISCUSSION
This paper examined immunization behavior in response to the appearance of a new influenza virus in the summer and fall of 2009, and examined what factors were correlated with a child's vaccination within 3 months of the emergency vaccine's availability. Models predicted receipt of a first dose by January 1, 2010, for all children aged 6 months through 17 years-this dose would have insured full immunity for children over age 10 and partial immunity for younger children. A second model predicted receipt of a second dose by February 1, 2010, among younger children who had received a first dose.
Consistent with previous research, [10] [11] [12] 18 this study found disparities in children's access to first pH1N1 vaccinations, and among younger children receiving their second vaccination. In particular, non-Hispanic black children and children living in different types of non-nuclear families were less likely to receive timely vaccinations, as were children living in families with lower income and with a parent (or parents) who had not attended college. However, receipt of WIC benefits and public health insurance coverage were positively associated with pH1N1 vaccinations, thus offsetting these disparities to some extent.
Children with asthma or chronic conditions were not any more likely to have received a pH1N1 vaccination than healthy children-this is a somewhat surprising finding that is at odds with previous research. 12 However, children's 2010 . Thus, the lack of any direct relationship between receipt of a pH1N1 vaccination and children's health may be explained, in part, by receipt of a seasonal flu vaccination, which ultimately underscores the importance that existing immunization programs may play during a pandemic.
Limitations of the Data
Cross-sectional survey data based on respondent assessments are typically subject to data limitations, such as recall problems and not understanding the interviewer's questions. In addition, adult respondents were not asked to consult immunization records for the child. Previous research has shown that immunization estimates based only on parental reports of children's vaccinations are higher than estimates based on provider records of immunizations, which are considered more reliable. 32, 33 With the exception of the indicator for age, other explanatory variables in the analyses reflected characteristics at the time of interview, which occurred after the immunization(s). Furthermore, the 2010 NHIS did not ask whether the sample child had been diagnosed with the pH1N1 virus, so that these children could not be excluded. In addition, the survey did not obtain any information regarding parents' perceptions of the effectiveness or safety of the vaccine, the likelihood that their child might contract the pH1N1 virus, or the health risks that this flu virus might pose for their child. 34 These represent unmeasurable factors that parents might take into consideration when deciding whether to have their child vaccinated.
In addition, the analysis assumes that vaccine supplies were uniformly available throughout the United States as of October 5, 2009 , but this may not have been the case. Some states and counties may have encountered shortfalls and rationed supplies, but the NHIS did not ask whether respondents experienced delays in obtaining H1N1 vaccinations for their children.
CONCLUSIONS
Although the US Public Health system was able to vaccinate 40.2% (29.1 million) of children during October 2009 and May 2010, 35 this is still well below the immunization numbers that would be necessary to protect healthy children from a highly contagious virus. 10, 36, 37 Fortunately, the pH1N1 virus in the United States peaked in October 2009, 38 which was about the same time that the vaccine became widely available, so that final morbidity and mortality rates were not as high as public health officials had at first feared. The 2009-2010 pH1N1 pandemic nevertheless serves as an important learning experience that can provide officials with additional insights to help them prepare for the next pandemic, which may be more severe.
